Search
for
Sort by
Research 61–90 of 1000+
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- THU0189 Safety of four treatment regimens in early rheumatoid arthritis
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Evaluation and treatment of male and female pattern hair loss
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- Management of Hair Loss
- Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Androgens in women
- Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Post‐COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia
- Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata
- Androgens in women
- Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: Lack of lasting improvement or cure in the majority of patients
- Tinea capitis in adult women masquerading as bacterial pyoderma
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening
- Treatment of severe alopecia areata with baricitinib
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes